Year: 2022
Type: article
Abstract: Healthy adipose tissue remodeling depends on the balance between de novo adipogenesis from adipogenic progenitor cells and the hypertrophy of adipocytes. De novo adipogenesis has been shown to promote healthy adipose tissue expansion, which confers protection from obesity-associated insulin resistance. Here, we define the role and trajectory of different adipogenic precursor subpopulations and further delineate the mechanism and cellular trajectory of adipogenesis, using single-cell RNA-sequencing datasets of murine adipogenic precursors. We identify Rspo2 as a functional regulator of adipogenesis, which is secreted by a subset of CD142+ cells to inhibit maturation of early progenitors through the receptor Lgr4. Increased circulating RSPO2 in mice leads to adipose tissue hypertrophy and insulin resistance and increased RSPO2 levels in male obese individuals correlate with impaired glucose homeostasis. Taken together, these findings identify a complex cellular crosstalk that inhibits adipogenesis and impairs adipose tissue homeostasis.
Source: Nature Metabolism
Institutions: ETH Zurich, Institute of Food, Nutrition, and Health, Boehringer Ingelheim (Germany), Slovak Academy of Sciences, Institute of Experimental Endocrinology of the Slovak Academy of Sciences, Biomedical Research Center of the Slovak Academy of Sciences, Comenius University Bratislava, Helmholtz Munich, University Hospital Leipzig, Leipzig University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $11,390
OpenAlex ID: W4205990284
